MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Solution Peptides
153 products · 275 listings
Daily snapshot · inspect sources
Product comparison
NAD+ Atomized Solution Kit prices
Compare NAD+ Atomized Solution Kit listings by strength, selection and supplier. Inspect the original source behind each price.
1suppliers represented
2source-linked listings
0strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
Comparable quantities are not established for these source-defined selections. Inspect the original listing before comparing.
Reported quantities in this family: not established. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. 2 listings in this family have incomplete quantity details and receive no inferred per-mg price.
Suppliers with NAD+ Atomized Solution Kit listings
1 profilesSources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more selection listings
FROM PEPTIDES CALCULATOR
About NAD+
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, where it carries electrons through glycolysis and the citric acid cycle and serves as the substrate consumed by sirtuins, PARP enzymes and CD38. Tissue levels fall with age and with oxidative stress, which is the rationale behind the wellness industry's NAD-boosting products: oral precursors such as nicotinamide riboside and nicotinamide mononucleotide, and parenteral NAD+ itself given by intravenous drip or subcutaneous injection. It is not approved by the FDA for any indication, injectable forms are compounded preparations that receive no pre-market review, and a 2026 systematic review found no outcome trials at all of intravenous or intramuscular NAD+ for anti-aging or wellness use. Because it is a dinucleotide rather than a peptide, it has no amino acid sequence.
- Formula
- C21 H27 N7 O14 P2
- Molar mass
- 663.4 g/mol
- CAS number
- 53-84-9
Research evidence described in the source
Small IV pharmacokinetic pilot
Eight participants received 750 mg NAD+ over six hours; the study measured metabolite handling, not clinical efficacy.
Precursor evidence is not direct NAD+ evidence
Human NR and NMN trials cannot be automatically generalized to injected NAD+.
Clinical outcomes remain inconclusive
Reviews find biochemical target engagement more consistently than meaningful health outcomes.
Limitations noted in the source
- NAD+, NADH, NR, NMN, niacin, and nicotinamide are related but non-interchangeable interventions.
- Direct IV/IM NAD+ lacks large randomized outcomes trials for anti-aging or wellness claims.
- A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
- Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.